BACCI: A Phase II Randomized, Double-Blind, Placebo-Controlled Study of Capecitabine Bevacizumab plus Atezolizumab versus Capecitabine Bevacizumab plus Placebo in Patients with Refractory Metastatic Colorectal Cancer
Clinical Trial Grant
Awarded By
Academic and Community Cancer Research United
Start Date
June 16, 2017
End Date
May 31, 2023
Awarded By
Academic and Community Cancer Research United
Start Date
June 16, 2017
End Date
May 31, 2023